Overcoming Challenges of Testing Cellular Immunity in Immuno-Oncology Drug Development


Tuesday, December 14, 2021
11:00 AM - 12:00 PM EST (5:00 PM - 6:00 PM CET)


Online Webinar
digital rendering of a cancer cell

Webinar Overview

Checkpoint targeted immunotherapies have caused a paradigm shift in immuno-oncology, yet, significant interest remains in the search for novel targets or testing combination therapies in physiologically relevant models where the CD8 T cell is center-stage.

Join this webinar to understand the safety of your drug as well as the therapeutic effect it has on the immune system. We will closely examine two case studies covering an array of topics including:

  • Pharmacology data using physiologically relevant in vitro models
  • Potential side-effects during an active immune response in a large animal model
  • Antigen-specific T cell populations and the effect on the kinetics of induction and maintenance of immunity


Webinar Presenters

Louise Brackenbury Headshot

Louise Brackenbury, PhD
Associate Director of Innovation, Discovery Services
Charles River

Richard Graveline Headshot

Richard Graveline, PhD
Senior Scientist Immunology
Charles River


Have a scheduling conflict? Sign up even if you can't make it; we'll share the recording after.


We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.